Show simple item record

Efficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: integrated analysis from three clinical trials

dc.contributor.authorSiena, S
dc.contributor.authorDoebele, RC
dc.contributor.authorShaw, AT
dc.contributor.authorKarapetis, CS
dc.contributor.authorTan, DSW
dc.contributor.authorCho, BC
dc.contributor.authorKim, DW
dc.contributor.authorAhn, MJ
dc.contributor.authorKrebs, Matthew G
dc.contributor.authorGoto, K
dc.contributor.authorLopez, PG
dc.contributor.authorFarago, AF
dc.contributor.authorLoong, HHF
dc.contributor.authorTosi, D
dc.contributor.authorBarve, MA
dc.contributor.authorSimmons, BP
dc.contributor.authorYe, CL
dc.contributor.authorEng, S
dc.contributor.authorDrilon, AE
dc.date.accessioned2019-11-19T16:01:08Z
dc.date.available2019-11-19T16:01:08Z
dc.date.issued2019en
dc.identifier.citationSiena S, Doebele RC, Shaw AT, Karapetis CS, Tan DS-W, Cho BC, et al. Efficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: integrated analysis from three clinical trials. J Clin Oncol. 2019;37(15_suppl):3017-.en
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.3017en
dc.identifier.urihttp://hdl.handle.net/10541/622467
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2019.37.15_suppl.3017en
dc.titleEfficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: integrated analysis from three clinical trialsen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, and Department of Oncology and Hemato-Oncology, Universit� degli Studi di Milano, Milan, Italyen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record